Medications with extensive first-pass hepatic metabolism can produce excessive blood levels and side effects at standard dosages in the setting of liver disease and should be carefully titrated.
Medications with extensive first-pass hepatic metabolism can produce excessive blood levels and side effects at standard dosages in the setting of liver disease and should be carefully titrated.